April saw a sustained barrage of Federal Reserve speeches and events. One count was of 45 meetings in just 20 days. With the US banking system continuing to display signs of pressure on the regional banks, central bankers were keen to demonstrate the situation was under control. We continue to see deposit flight to larger better capitalised institutions. The message from the central banks is still that they will reduce global liquidity to tame inflation, and that the US economy is set for a mild recession.
The month saw many companies report earnings. As is typical earnings estimates tend to be well managed by corporates in advance of reporting. Given a weakening economy and typical over optimism for many companies third party estimates generally declined in advance of announcements decreasing the importance of results versus consensus estimates, and enhancing the importance of future guidance from companies. We have for some time been focused on trying to position the fund with companies that can deal with elevated levels of inflation. Pleasingly the consumer staples names held have successfully been passing on inflation, and our healthcare, technology companies and the luxury goods names have also been less impacted than the general market.
With so much uncertainty about the future direction of central banks, and economies it was not surprising that markets were volatile. Generally shares of higher quality, less cyclical and lower growth, companies performed better than lower quality and higher growth companies. The best performing shares during the month were those providing positive earnings updates and outlooks, and conversely those that disappointed saw particularly severe share price declines.
The FTSE All World Index gained 1.6% during the month and the Global Leaders Fund (I Class USD) gained 1.8%. The best performers held were Novartis +11.7%, Ping An +11.0% and Hannover Re +9.1%. While the worst performers held were Alibaba -17.1%, NXP Semi -12.2% and TSMC -6.6%.
Novartis surprised the market, and in fact us, with better than anticipated operational performance and uptake of new products, as well as encouraging update from their generics division. After the heightened interest in the company following the unveiling of their plan to split into six, there was little news for Alibaba during April. We would anticipate more detailed information on divisional plans to be received positively in the future, and meanwhile note the continued rebound in economic activity in China.
Dr James Cooke
Director of Investments and Head of Global Equities
Dr James Cooke is Director of Investments and Head of Global Equities for Ashburton Investments (International). James joined us from Asset Risk Consultants (ARC) where he was an Investment Consultant responsible for advising high net worth clients, trusts and charities on investment strategy, strategic asset allocation and discretionary fund manager selection. Previously he was based in Edinburgh, as an Investment Manager with SVM Asset Management where he spent seven years working on their World Equity strategy and providing ideas for other funds. During his time at SVM, the firm was consistently ranked within the top 10 UK based fund manager groups by FundCalibre. Prior to this he was a full member of the investment committee at Edinburgh Partners, recently acquired by Franklin Templeton, then managing over $10bn of global equity investments. He maintains a keen interest in Corporate Governance having previously advised firms on these matters with Towers Perrin, now Willis Towers Watson, before joining the investment industry. James is a CFA charterholder and holds a BEng(Hons) degree in Chemical Engineering from the University of Edinburgh, both an MSc and a PhD in Biochemical Engineering from University College London.
Dr James Cooke’s latest insights
View all (182)
Funds managed by Dr James Cooke
Kathy covers global equities for Ashburton’s International team. She joined the team in South Africa in 2013 as an Equity Research Analyst for the African Equity Opportunities Fund, having moved home from the UK in 2010. Kathy has experience covering listed Pan-European retail stocks and South African listed retail sector. Kathy holds a Bachelor of Commerce (IT and accounting) degree from the University of the Witwatersrand, a Masters of Professional Accounting from the University of Southern Queensland, and is a Chartered Financial Advisor charterholder.
Kathy Davey’s latest insights
View all (8)
Funds managed by Kathy Davey
The content or fund you have selected is not available for the profile or region you have selected.
Please select one of the options below to return to the site.